Dr. Stephanie Seremetis is CVP and Chief Medical Officer for Rare Disease and Advanced Therapies at Novo Nordisk. Before joining Novo Nordisk, she was Associate Professor in the Departments of Medicine and Geriatrics at the Mount Sinai School of Medicine in New York, as well as Director of the Regional Comprehensive Hemophilia Diagnostic and Treatment Center.
Dr. Seremetis has authored numerous publications in the areas of hematology and hemophilia and has been a reviewer for many medical journals, including The New
England Journal of Medicine, The Journal of the American Medical Association and The Lancet. She has also served on many committees for organizations such as the American Society of Hematology, the National Hemophilia Foundation, the National Institutes of Health and the World Health Organization.
Monday, July 11, 2022
12:15 PM – 12:20 PM
Monday, July 11, 2022
12:40 PM – 1:00 PM